The Motley Fool

Got $2,000? Here are 2 ASX 200 healthcare shares to buy today

ASX 200 healthcare shares have had a rollercoaster ride in 2020. While the S&P/ASX 200 Index (ASX: XJO) is down 18.36% this year, the nature of the coronavirus pandemic has meant investors are snapping up healthcare companies like there’s no tomorrow.

Here are a couple of my top healthcare shares to buy for a good price today!

2 ASX 200 healthcare shares to buy today

I like the look of CSL Limited (ASX: CSL) shares right now. The biotech giant’s share price closed at $290.93 on Friday and boasts a $132 billion market capitalisation.

On the surface, that may seem expensive. However, I think we’ve seen some strong support for CSL shares at the $300 per share mark. Given the group’s size and demand for its products, the ASX 200 healthcare share could be in the buy zone.

Despite climbing higher in 2020, the CSL share price is down 11% since early April. That could mean now is a good time to buy in and hold a blue-chip share for the long-term.

Other than CSL, I think Polynovo Ltd (ASX: PNV) shares could be in the buy zone. Polynovo develops and manufactures polymers to assist with the treatment of burns and its share price has been flying in recent years.

In fact, the ASX 200 healthcare share is up more than 100% since 23 March and more than 3,300% in the last 5 years. 

Those are some strong growth numbers and there could be more on the way. The Aussie biotech group is going from strength to strength and posted record US quarterly sales in the March quarter.

The group’s NovoSorb Biodegradable Temporising Matrix (BTM) product has had success in a number of countries and received widespread praise from the medical community.

There’s still further market share for Polynovo to capture and a strong research and development pipeline could drive further growth for the ASX 200 healthcare share.

Foolish takeaway

ASX 200 healthcare shares could be good buy options in the COVID-19 environment. There are strong dividend and growth shares for savvy investors but you just have to know where to look…

For more great value ASX shares, check out these 5 top picks today!

NEW! 5 Cheap Stocks With Massive Upside Potential

Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer.

One is a diversified conglomerate trading 40% off it's all-time high, all while offering a fully franked dividend yield of over 3%...

Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.

Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.

Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.

But you will have to hurry because the cheap share prices on offer today might not last for long.

YES! SEND ME THE FREE REPORT!

Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.